These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19382984)

  • 1. Reversible posterior leucoencephalopathy syndrome associated with sunitinib.
    Chen A; Agarwal N
    Intern Med J; 2009 May; 39(5):341-2. PubMed ID: 19382984
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe neurological symptoms in a patient with advanced renal cell carcinoma treated with sunitinib.
    Duchnowska R; Miciuk B; Bodnar L; Waśniewski L; Szczylik C
    J Oncol Pharm Pract; 2013 Jun; 19(2):186-9. PubMed ID: 23037634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible posterior leukoencephalopathy syndrome following sunitinib therapy: a case report and review of the literature.
    Khan KH; Fenton A; Murtagh E; McAleer JJ; Clayton A
    Tumori; 2012; 98(5):139e-142e. PubMed ID: 23235770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible posterior leucoencephalopathy syndrome in an elderly male on sunitinib therapy.
    Padhy BM; Shanmugam SP; Gupta YK; Goyal A
    Br J Clin Pharmacol; 2011 May; 71(5):777-9. PubMed ID: 21480952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversible posterior leukoencephalopathy syndrome with the neuroradiological abnormalities predominantly in the brainstem].
    Abiko M; Ikawa F; Obayashi N; Kajiwara Y; Mitsuhara T; Ichinose N; Inagawa T
    Brain Nerve; 2008 Sep; 60(9):1080-1. PubMed ID: 18807944
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible posterior leukoencephalopathy or leucoencephalopathy?
    Caminal-Montero L; Trapiella-Martínez L; Díaz-López JB
    Semin Arthritis Rheum; 2007 Oct; 37(2):135; author reply 135. PubMed ID: 17509669
    [No Abstract]   [Full Text] [Related]  

  • 7. Bortezomib-induced reversible posterior leucoencephalopathy syndrome.
    Kelly K; Kalachand R; Murphy P
    Br J Haematol; 2008 May; 141(5):566. PubMed ID: 18325065
    [No Abstract]   [Full Text] [Related]  

  • 8. Sunitinib-induced acute hemolysis without hypertension: a case report.
    Jain R; Mathew P; Wood CG; Tannir NM
    Clin Genitourin Cancer; 2008 Sep; 6(2):122-3. PubMed ID: 18824436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible posterior leucoencephalopathy syndrome in post streptococcal glomerulonephritis.
    Gupta S; Goyal VK; Talukdar B
    Indian Pediatr; 2010 Mar; 47(3):274-6. PubMed ID: 20371895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
    Martín G; Bellido L; Cruz JJ
    J Clin Oncol; 2007 Aug; 25(23):3559. PubMed ID: 17687168
    [No Abstract]   [Full Text] [Related]  

  • 11. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.
    Kapiteijn E; Brand A; Kroep J; Gelderblom H
    Ann Oncol; 2007 Oct; 18(10):1745-7. PubMed ID: 17890216
    [No Abstract]   [Full Text] [Related]  

  • 12. Posterior reversible encephalopathy syndrome after long-term treatment with low-dose sunitinib: a case report.
    Saraceno L; Ricigliano VAG; Cavalli M; Meola G
    Neurol Sci; 2017 Jun; 38(6):1119-1121. PubMed ID: 28224329
    [No Abstract]   [Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!
    Khurana A; Dasanu CA
    J Oncol Pharm Pract; 2015 Dec; 21(6):443-50. PubMed ID: 25013187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.
    Pinedo DM; Shah-Khan F; Shah PC
    J Clin Oncol; 2007 Nov; 25(33):5320-1. PubMed ID: 18024878
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible posterior encephalopathy syndrome in pregnancy without pre-eclampsia.
    Amin A; Jones I; Eskandar O
    J Obstet Gynaecol; 2015; 35(6):643-4. PubMed ID: 25528891
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.
    Han CH; Findlay MP
    Intern Med J; 2010 Feb; 40(2):153-9. PubMed ID: 20446957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible posterior encephalopathy syndrome associated with bortezomib.
    Terwiel E; Hanrahan R; Lueck C; D'Rozario J
    Intern Med J; 2010 Jan; 40(1):69-71. PubMed ID: 20561367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib-aggravated hypertension.
    Rivera F; Benounna M; Sánchez de la Nieta MD
    J Hypertens; 2009 Jul; 27(7):1502-3. PubMed ID: 19542988
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical reversible posterior leukoencephalopathy syndrome in a chronic haemodialysis patient with severe hypertension.
    Park J; Choi SH; Kwon JH; Chung HC; Lee JS
    Nephrology (Carlton); 2008 Dec; 13(6):542-3. PubMed ID: 19138210
    [No Abstract]   [Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome during sunitinib therapy.
    Cumurciuc R; Martinez-Almoyna L; Henry C; Husson H; de Broucker T
    Rev Neurol (Paris); 2008; 164(6-7):605-7. PubMed ID: 18565360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.